Department of Urology Skåne University Hospital, Malmö, Sweden.
Institution of Translational Medicine, Lund University, Malmö, Sweden.
PLoS One. 2023 Feb 2;18(2):e0281304. doi: 10.1371/journal.pone.0281304. eCollection 2023.
Intravesical recurrence (IVR) after surgery for upper tract urothelial carcinoma (UTUC) is a clinical problem. We investigated if preoperative invasive diagnostic modalities (IDM) such as antegrade/retrograde uretero-pyelography and/or selective urine cytology/barbotage, and URS with or without concomitant biopsy are associated with IVR after radical surgery for UTUC. Risk of death from urothelial cancer and all causes was investigated as secondary outcomes.
We investigated a population-based cohort of 1038 consecutive patients subjected to radical surgery for UTUC 2015-2019 in Sweden, using the Bladder Cancer Data Base Sweden (BladderBaSe 2.0), comprising all patients in the Swedish National Registry of Urinary Bladder Cancer. Risk estimates of IVR, death from urothelial cancer, and all causes was assessed using multivariable Cox regression models.
The study included 536 cases with and 502 without preoperative IDM. IDM was associated with increased risk of IVR (HR 1.24, 95% CI 1.03-1.52) and risk of urothelial cancer death (HR 1.56, CI 1.12-2.18), compared to no IDM after a median follow-up of 1.3 yrs. Stratified analysis for tumor location showed that IDM was associated with risk of IVR in ureteric cancer (HR 1.66, 95% CI 1.21-2.28) but not in renal pelvic cancer (HR 1.07, 95% CI 0.81-1.41). Limitations included the observational setting and the lack of variables such as tumour grade, multifocality and preoperative hydronephrosis.
Worse outcomes for patients subjected to preoperative IDM highlight the need for carefully considering diagnostic decisions for UTUC patients, specifically in tumours located in the ureter.
上尿路尿路上皮癌(UTUC)手术后的膀胱内复发(IVR)是一个临床问题。我们研究了术前侵袭性诊断方法(IDM),如顺行/逆行输尿管肾盂造影和/或选择性尿液细胞学/灌洗,以及是否联合活检的输尿管镜检查(URS)与 UTUC 根治术后 IVR 的关系。还调查了因尿路上皮癌和所有原因导致的死亡风险作为次要结局。
我们调查了 2015 年至 2019 年在瑞典接受 UTUC 根治术的 1038 例连续患者的基于人群的队列,使用膀胱癌数据库瑞典(BladderBaSe 2.0),该数据库包含瑞典国家膀胱癌登记处的所有患者。使用多变量 Cox 回归模型评估 IVR、死于尿路上皮癌和所有原因的风险估计。
研究包括 536 例有术前 IDM 和 502 例无术前 IDM 的病例。与无术前 IDM 相比,IDM 与 IVR 风险增加(HR 1.24,95%CI 1.03-1.52)和尿路上皮癌死亡风险增加(HR 1.56,CI 1.12-2.18)相关,中位随访 1.3 年后。按肿瘤位置进行分层分析显示,IDM 与输尿管癌的 IVR 风险相关(HR 1.66,95%CI 1.21-2.28),但与肾盂癌无关(HR 1.07,95%CI 0.81-1.41)。局限性包括观察性设置以及缺乏肿瘤分级、多灶性和术前肾积水等变量。
接受术前 IDM 的患者结局更差,这突显了需要仔细考虑 UTUC 患者的诊断决策,特别是在输尿管肿瘤中。